A detailed history of Virtu Financial LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 7,219 shares of RNA stock, worth $240,392. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,219
Holding current value
$240,392
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$29.08 - $52.5 $209,928 - $378,997
7,219 New
7,219 $210,000
Q3 2022

Nov 07, 2022

BUY
$15.46 - $23.43 $28,987 - $43,931
1,875 Added 11.45%
18,252 $298,000
Q2 2022

Aug 09, 2022

BUY
$11.18 - $20.5 $183,094 - $335,728
16,377 New
16,377 $238,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.74B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.